Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nutrition and enterocutaneous fistulas.

Z A Makhdoom1, M J Komar, C D Still

  • 1Section of Gastroenterology/Nutrition, Penn State Geisinger Medical Center, Danville, Pennsylvania 17822, USA. Zmakhdoom@psghs.edu

Journal of Clinical Gastroenterology
|October 18, 2000
PubMed
Summary

Enterocutaneous fistulas (ECFs) are complex, with high risks. Somatostatin or octreotide, alongside total parenteral nutrition, may reduce ECF healing time and complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of multi-frequency bioelectrical impedance analysis for the assessment of body composition in individuals with obesity.

Obesity science & practice·2019
Same author

Response to 'Regression to the mean, apparent data errors, and biologically extraordinary results'.

International journal of obesity (2005)·2017
Same author

Changes in telomere length 3-5 years after gastric bypass surgery.

International journal of obesity (2005)·2017
Same author

Electronically captured, patient-reported physical function: an important vital sign in obesity medicine.

Obesity science & practice·2017
Same author

Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity.

International journal of obesity (2005)·2013
Same author

The effect of weight loss surgery on the severity of psoriasis.

The British journal of dermatology·2012

Area of Science:

  • Gastroenterology
  • Surgical Complications
  • Clinical Nutrition

Background:

  • Enterocutaneous fistulas (ECFs) present significant management challenges.
  • High morbidity and mortality associated with ECFs stem from fluid/electrolyte imbalance, sepsis, and malnutrition.
  • Prognostic factors for ECF outcomes are largely established.

Purpose of the Study:

  • To review the complex classification and treatment of ECFs.
  • To evaluate the role of adjuvant pharmacotherapy in managing high-output ECFs.
  • To assess the efficacy of somatostatin and octreotide in ECF treatment.

Main Methods:

  • Literature review of ECF classification, prognostic factors, and treatment modalities.
  • Analysis of clinical data regarding conservative and surgical management strategies.

Related Experiment Videos

  • Evaluation of studies utilizing somatostatin and octreotide in conjunction with total parenteral nutrition.

    • Main Results:

    • ECF treatment requires tailored approaches, including surgical or conservative/medical options.
    • Nutritional support (enteral or parenteral) is critical and depends on fistula site and patient status.
    • Somatostatin (250 microg/d) and octreotide (300-600 microg/d) show promise as adjuvant therapies with total parenteral nutrition for high-output ECFs.

    Conclusions:

    • Adjuvant somatostatin or octreotide, combined with total parenteral nutrition, can decrease healing time for refractory high-output ECFs.
    • These pharmacologic agents may reduce complication rates associated with ECFs.
    • Personalized treatment strategies remain essential for optimizing ECF patient outcomes.